American Society of Hematology, Blood, 19(124), p. 2898-2900, 2014
DOI: 10.1182/blood-2014-09-600635
Full text: Download
In this issue of Blood, Wang et al report on the response of splenic-derived hematopoietic stem and progenitor cells from patients with myelofibrosis (MF) to the Janus kinase (JAK) inhibitor, AZD1480.